Document Detail

Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review).
MedLine Citation:
PMID:  12469179     Owner:  NLM     Status:  MEDLINE    
Cancer of the prostate is the most commonly diagnosed solid malignancy and the second leading cause of cancer-related death in men living in developed countries. With an ageing population, the number of men living with early stages of prostate cancer is expected to increase. There is an increasing need to prevent the onset of cancer or delay the progression of carcinogenesis in this organ. Chemoprevention is the administration of pharmacological agents to prevent, delay or reverse carcinogenesis. An example is the reversal of high grade intraepithelial neoplasia by hormonal manipulation using anti-oestrogens in breast carcinogenesis or anti-androgens in prostate carcinogenesis. Epidemiological data showing ethnic and geographic variations in the incidence of, and mortality from, prostate cancer have suggested that the consumption of certain dietary factors, particularly anti-oxidants, may be protective. These factors include the vitamins D and E, soy, lycopene and selenium. The administration of 5-alpha reductase inhibitors to patients with benign prostatic hyperplasia may also constitute a potentially chemopreventive intervention. The efficacy of chemopreventive agents needs to be investigated in randomised, placebo-controlled trials in suitable cohorts of high-risk individuals. In parallel, reliable assays of potential biomarkers of the efficacy of intervention need to be developed and validated rigorously.
S K Pathak; R A Sharma; J K Mellon
Related Documents :
11295609 - Magnetic resonance imaging and spectroscopic imaging: improved patient selection and po...
23956309 - New treatment options for patients with metastatic prostate cancer.
12706869 - Cancer chemopreventive activity of acridone alkaloids on epstein-barr virus activation ...
22262269 - Cutaneous melanoma in latin america: the need for more data.
11232189 - Hepatocellular cancer. a century of progress.
15901989 - Black tea polyphenols suppress cell proliferation and induce apoptosis during benzo(a)p...
1321619 - Human lung adrenergic and muscarinic cholinergic receptors in cancer and previous airwa...
23690779 - Mitochondrial complex i inhibitors and forced oxidative phosphorylation synergize in in...
12858219 - Cancer epidemiology in hungary and the béla johan national program for the decade of h...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  International journal of oncology     Volume:  22     ISSN:  1019-6439     ISO Abbreviation:  Int. J. Oncol.     Publication Date:  2003 Jan 
Date Detail:
Created Date:  2002-12-06     Completed Date:  2003-06-16     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9306042     Medline TA:  Int J Oncol     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  5-13     Citation Subset:  IM    
Cancer Biomarkers and Prevention Group, Department of Oncology, University of Leicester, Leicester, LE2 7LX, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticarcinogenic Agents / pharmacology,  therapeutic use*
Antioxidants / pharmacology,  therapeutic use*
Carotenoids / therapeutic use
Dietary Fats / administration & dosage
Enzyme Inhibitors / therapeutic use
Prostatic Neoplasms / prevention & control*
Testosterone 5-alpha-Reductase / antagonists & inhibitors
Vitamin D / therapeutic use
Vitamin E / therapeutic use
Reg. No./Substance:
0/Anticarcinogenic Agents; 0/Antioxidants; 0/Dietary Fats; 0/Enzyme Inhibitors; 1406-16-2/Vitamin D; 1406-18-4/Vitamin E; 36-88-4/Carotenoids; 502-65-8/lycopene; EC 5-alpha-Reductase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Enkephalin degradating enzymes in pheochromocytoma patients.
Next Document:  Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review).